{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:46Z","timestamp":1707525106336},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,17]]},"DOI":"10.7759\/cureus.37700","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T16:41:30Z","timestamp":1681749690000},"source":"Crossref","is-referenced-by-count":0,"title":["Bupropion Treatment for Stimulant Withdrawal in a Patient With Substance Use Disorder and Unspecified Bipolar Disorder"],"prefix":"10.7759","author":[{"given":"Daanish Y","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita C","family":"Behaeddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stepan","family":"Uhlyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone D","year":"2011","unstructured":"Ciccarone D. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care Clin Off Pract. 2011, 38:41-58. 10.1016\/j.pop.2010.11.004","journal-title":"Prim Care Clin Off Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.0584","article-title":"Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders","volume":"36","author":"Han B","year":"2017","unstructured":"Han B, Compton WM, Blanco C, et al.. Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders. Health Affairs. 2017, 36:1739-47. 10.1377\/hlthaff.2017.0584","journal-title":"Health Affairs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2016.08.008","article-title":"A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014","volume":"92","author":"Davis D","year":"2016","unstructured":"Davis D, Kurti A, Skelly J, et al.. A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014. Prev Med. 2016, 92:36-46. 10.1016\/j.ypmed.2016.08.008","journal-title":"Prev Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2018.01.004","article-title":"Evaluation and management of hypoactive sexual desire disorder","volume":"6","author":"Clayton AH","year":"2018","unstructured":"Clayton AH, Kingsberg SA, Goldstein I. Evaluation and management of hypoactive sexual desire disorder. Sex Med. 2018, 6:59-74. 10.1016\/j.esxm.2018.01.004","journal-title":"Sex Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009504.pub2","article-title":"Bupropion for attention deficit hyperactivity disorder (ADHD) in adults","volume":"10","author":"Verbeeck W","year":"2017","unstructured":"Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2017, 10:10.1002\/14651858.CD009504.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003021.pub2","article-title":"Treatment for amphetamine withdrawal","volume":"2","author":"Shoptaw SJ","year":"2009","unstructured":"Shoptaw SJ, Kao U, Heinzerling K, Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev. 2009, 2:10.1002\/14651858.CD003021.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1300\/J069v21n02_01","article-title":"Bupropion treatment for cocaine abuse and adult attention-deficit\/hyperactivity disorder","volume":"21","author":"Levin FR","year":"2002","unstructured":"Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E. Bupropion treatment for cocaine abuse and adult attention-deficit\/hyperactivity disorder. J Addict Dis. 2002, 21:1-16. 10.1300\/J069v21n02_01","journal-title":"J Addict Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300979","article-title":"Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving","volume":"31","author":"Newton TF","year":"2005","unstructured":"Newton TF, Roache JD, De La Garza R, et al.. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacol. 2005, 31:1537-44. 10.1038\/sj.npp.1300979","journal-title":"Neuropsychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling J","year":"2006","unstructured":"Poling J, Oliveto A, Petry N, et al.. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006, 63:219-28. 10.1001\/archpsyc.63.2.219","journal-title":"Arch Gen Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.6.9.1249","article-title":"Bupropion: pharmacology and therapeutic applications","volume":"6","author":"Foley KF","year":"2006","unstructured":"Foley KF, DeSanty KP, Kast RE. Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother. 2006, 6:1249-65. 10.1586\/14737175.6.9.1249","journal-title":"Expert Rev Neurother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000049259","article-title":"Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients","volume":"45","author":"Erfurth A","year":"2002","unstructured":"Erfurth A, Michael N, Stadtland C, Arolt V. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients. Neuropsychobiol. 2002, 45:33-6. 10.1159\/000049259","journal-title":"Neuropsychobiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149411-bupropion-treatment-for-stimulant-withdrawal-in-a-patient-with-substance-use-disorder-and-unspecified-bipolar-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:35Z","timestamp":1707508535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149411-bupropion-treatment-for-stimulant-withdrawal-in-a-patient-with-substance-use-disorder-and-unspecified-bipolar-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.37700","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,17]]}}}